Revance Therapeutics Inc (NASDAQ:RVNC)
| 10.81 BATS BZX Real-Time Price As of 11:33am ET |  -0.39 / -3.48%Today’s Change | 10.70 Today|||52-Week Range 37.98 | -41.44% Year-to-Date |
Latest RVNC News | Press Releases
No recent news for Revance Therapeutics Inc.
Today’s Trading
| Previous close | 11.20 |
| Today’s open | 11.09 |
| Day’s range | 10.70 - 11.17 |
| Volume | 12,932 |
| Average volume (3 months) | 1,644,348 |
| Market cap | $1.0B |
Data as of 11:33am ET, 10/03/2023
Growth & Valuation
| Earnings growth (last year) | -17.63% |
| Earnings growth (this year) | +12.69% |
| Earnings growth (next 5 years) | +192.00% |
| Revenue growth (last year) | +70.40% |
| P/E ratio | NM |
| Price/Sales | 10.13 |
| Price/Book | 75.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QTRXQuanterix Corp | +0.65 | +2.43% |
| ---- | ||
| ---- | ||
| LGNDLigand Pharmaceutica... | -0.19 | -0.32% |
Data as of 11:31am ET, 10/03/2023
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | -$0.67 |
| Annual revenue (last year) | $132.6M |
| Annual profit (last year) | -$356.4M |
| Net profit margin | -268.87% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Nashville, Tennessee |
Forecasts
